What is the best treatment and the most cost effective treatment for patients with idiopathic pulmonary fibrosis (IPF): advice on breathlessness, or advice on breathlessness and oxygen to use whilst walking and doing other daily activities at home?
- Conditions
- Idiopathic pulmonary fibrosis (IPF)RespiratoryIdiopathic Pulmonary Fibrosis
- Registration Number
- ISRCTN16366011
- Lead Sponsor
- niversity of Birmingham
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 7
1. Aged 18 or over
2. Clinically diagnosed IPF, confirmed by an ILD MDT linked to an NHS specialist commissioned IPF service
3. Breathlessness with MRC dyspnoea score =2
4. Willing and able to comply with completion of questionnaires out to 6 months post-randomisation
5. Able to complete a 6MWT or 1 minute sit to stand test
6. Able to use oxygen safely in the opinion of the local investigator
1. Unable to provide informed consent
2. Requires LTOT, defined by need for resting oxygen in the opinion of the local investigator
3. Life expectancy <6 months
4. On the active transplant list
5. Previous acidotic hypercapnic respiratory failure (AHRF) requiring non-invasive ventilation (NIV)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method